Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in MPLT held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Novo Holdings A/S | 3.7M | $74.9M | 0.0% | 8.125% | 6.07% |
| 2 | FCPM III SERVICES B.V. | 3.2M | $65.6M | 0.0% | 7.111% | 9.08% |
| 3 | GOLDMAN SACHS GROUP INC | 2.0M | $40.6M | +3.0% | 4.397% | 0.00% |
| 4 | BlackRock, Inc. | 1.3M | $27.2M | +22.3% | 2.953% | 0.00% |
| 5 | Blue Owl Capital Holdings LP | 1.0M | $20.5M | +207.6% | 2.217% | 5.49% |
| 6 | Nan Fung Group Holdings Ltd | 971K | $19.7M | 0.0% | 2.141% | 16.28% |
| 7 | 5AM Venture Management, LLC | 950K | $19.3M | 0.0% | 2.094% | 5.36% |
| 8 | Sanofi | 912K | $18.5M | 0.0% | 2.010% | 5.52% |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 720K | $14.6M | β | 1.586% | 0.00% |
| 10 | Pivotal bioVenture Partners Investment Advisor LLC | 611K | $12.4M | 0.0% | 1.348% | 4.44% |
| 11 | Velan Capital Investment Management LP | 493K | $10.0M | -5.6% | 1.086% | 6.28% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 481K | $9.8M | +23.7% | 1.060% | 0.00% |
| 13 | Siren, L.L.C. | 450K | $9.1M | 0.0% | 0.992% | 0.25% |
| 14 | Vestal Point Capital, LP | 420K | $8.5M | +9.1% | 0.926% | 0.24% |
| 15 | ADAR1 Capital Management, LLC | 375K | $7.6M | β | 0.826% | 0.48% |
| 16 | BAKER BROS. ADVISORS LP | 365K | $7.4M | 0.0% | 0.804% | 0.04% |
| 17 | STATE STREET CORP | 339K | $6.9M | +47.8% | 0.747% | 0.00% |
| 18 | Freestone Grove Partners LP | 314K | $6.4M | +70.8% | 0.692% | 0.05% |
| 19 | BNP Paribas Asset Management Holding S.A. | 268K | $5.4M | +81.0% | 0.590% | 0.01% |
| 20 | RA CAPITAL MANAGEMENT, L.P. | 248K | $5.0M | β | 0.547% | 0.05% |
| 21 | UBS Group AG | 237K | $4.8M | +1193.1% | 0.521% | 0.00% |
| 22 | FMR LLC | 205K | $4.2M | +22521.8% | 0.451% | 0.00% |
| 23 | Board of Trustees of The Leland Stanford Junior University | 199K | $4.1M | 0.0% | 0.439% | 0.48% |
| 24 | SUPERSTRING CAPITAL MANAGEMENT LP | 192K | $3.9M | β | 0.423% | 2.79% |
| 25 | DAFNA Capital Management LLC | 171K | $3.5M | +18.9% | 0.377% | 0.79% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in MPLT β a direct measure of their conviction.
Filings activity in MPLT during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new MPLT position in Q1 2026
Institutions that fully closed their MPLT position in Q1 2026
2 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 80 | +8.1% | 35.17% | +7.10 pp | $443M | +25% |
| Q4 2025 | 74 | β | 28.07% | β | $353M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying MPLT stock.
Based on Q1 2026 13F filings, institutional ownership of MapLight Therapeutics, Inc. stands at 35.2%, held across 80 reporting institutions.
Novo Holdings A/S is the largest reported institutional holder of MPLT, with approximately 3,686,622 shares worth $0.07B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of MPLT.
Our composite Smart Money Score for MPLT is 49 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
22 institutions opened new positions in MPLT during Q1 2026, while 16 fully exited. 50 added to existing positions and 8 trimmed.
MPLT institutional ownership rose by 7.10 percentage points quarter-over-quarter, with a net change of +6 holders.
The top 10 institutions account for 70.8% of all reported 13F value in MPLT, and the top 25 account for 92.6%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
MapLight Therapeutics, Inc. (MPLT) Institutional Ownership